IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v30y2010i4p438-443.html
   My bibliography  Save this article

Prevalence of Antibodies Associated with Herd Immunity: A New Indicator to Evaluate the Establishment of Herd Immunity and to Decide Immunization Strategies

Author

Listed:
  • Pedro Plans

    (Health Department of Catalonia, General Directorate of Public Health, Barcelona, Spain, pedro.plans@gencat.net)

Abstract

Objective. To develop a method to estimate the critical prevalence of antibodies associated with herd immunity (p c ) and to assess the establishment of herd immunity against measles, mumps, rubella, varicella, and pertussis in Catalonia (Spain) using this method. Methods. The herd immunity is established when the prevalence of antibodies (positive serological results) is higher than p c = I c Se/PV, where I c is the prevalence of protected individuals necessary to block the transmission of an infection in the population, Se is the sensitivity of the serological test, and PV is the predictive value of a positive serological result. The establishment of herd immunity was assessed comparing the age-group specific p c with the prevalence of antibodies (p) observed in Catalonia in 2002 in schoolchildren (6—9 years) and individuals aged 14 to 29 years and 45 to 54 years. Results. The herd immunity was not established (p

Suggested Citation

  • Pedro Plans, 2010. "Prevalence of Antibodies Associated with Herd Immunity: A New Indicator to Evaluate the Establishment of Herd Immunity and to Decide Immunization Strategies," Medical Decision Making, , vol. 30(4), pages 438-443, July.
    • Handle: RePEc:sae:medema:v:30:y:2010:i:4:p:438-443
    DOI: 10.1177/0272989X09353453
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X09353453
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X09353453?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Masaya M. Saito & Keisuke Ejima & Ryo Kinoshita & Hiroshi Nishiura, 2018. "Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses," IJERPH, MDPI, vol. 15(4), pages 1-12, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:30:y:2010:i:4:p:438-443. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.